Get access

Hyperglycemic hyperosmolar non-ketotic syndrome in children with type 2 diabetes*

Authors

  • Shannon H. Fourtner,

    Corresponding author
    1. Department of Pediatrics, Division of Endocrinology/Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA; and
    Search for more papers by this author
  • Stuart A. Weinzimer,

    1. Yale Pediatric Endocrinology, Yale University School of Medicine, New Haven, CT, USA
    Search for more papers by this author
  • Lorraine E. Levitt Katz

    1. Department of Pediatrics, Division of Endocrinology/Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA; and
    Search for more papers by this author

  • *

    Presented in part at the annual meeting of the Endocrine Society, Philadelphia, PA, June 2003.

†Shannon H. Fourtner, MD
Children's Hospital of Philadelphia
University of Pennsylvania School of Medicine
Department of Pediatrics
Division of Endocrinology/Diabetes
34th and Civic Center Blvd
Philadelphia, PA 19104, USA
Tel: +1 267 426 5508;
fax: +1 215 590 1605;
e-mail: fourtner@email.chop.edu

Abstract

Objective:  Hyperglycemic hyperosmolar non-ketotic (HHNK) syndrome is thought to be a rare entity in the pediatric population, associated with significant mortality based on case reports in the literature. As obesity and type 2 diabetes in childhood grow in prevalence, such related complications may also increase. This study will serve to provide updated information regarding typical clinical course and sequelae of HHNK syndrome in childhood.

Methods:  Patients diagnosed with type 2 diabetes at Children's Hospital of Philadelphia (CHOP) over a period of 5 yr were screened retrospectively for any laboratory evidence of previous episodes of HHNK syndrome. The standard diagnostic criteria of blood glucose >600 mg/dL and serum osmolality >330 mOsm/L with only mild acidosis (serum bicarbonate >15 mmol/L and small ketonuria 15 mg/dL or less) were utilized.

Results:  The records of all patients with type 2 diabetes mellitus (DM) diagnosed over a 5-yr period were reviewed (n = 190). Seven patients were found to have one episode of HHNK syndrome by diagnostic criteria (five males, mean age at presentation 13.3 yr, age range 10.1–16.9 yr), yielding a frequency of 3.7%. All were African-American. HHNK syndrome was the clinical presentation at diagnosis of new onset diabetes for all seven children. Three of seven children had a previously diagnosed developmental delay. The average Glasgow Coma Scale (GCS) score at presentation was 13 (range 9–15). Mean body mass index (BMI) at presentation was 32.7 kg/m2 (n = 6). Mean serum osmolality was 393 mOsm/L (n = 7), and mean blood glucose was 1604 mg/dL (n = 7). The average time until mental status returned to baseline among survivors was 3 d (range 1–7 d). The average number of hospital days for survivors was 10 (range 5–24 d). Four of seven patients had an uncomplicated course. One patient developed multisystem organ failure and died on hospital day 4. The case fatality rate was 14.3% (one of seven). Survivors had no appreciable neurodevelopmental sequelae.

Conclusions:  This retrospective chart review provides updated information regarding the entity of HHNK syndrome in children. This study supports the need for increased awareness of type 2 diabetes in children so that morbidity and mortality related to HHNK syndrome can be prevented.

Ancillary